Serum Uric Acid-Lowering Effects of Combined Glycine and Tryptophan Treatments in Subjects with Mild Hyperuricemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Nutrients. 2019 Mar 6;11(3):564. doi: 10.3390/nu11030564.

Abstract

We determined the serum uric acid-lowering effects of combined daily supplementation of glycine and tryptophan in patients with mild hyperuricemia using a randomized, double-blind, placebo-controlled, crossover clinical trial design. Japanese healthy adult males and females with mild hyperuricemia (fasting serum uric acid of 6.6⁻7.9 mg/dL) ingested a powder mixture containing 3.0 g of glycine and 0.2 g of tryptophan or a placebo powder once daily at bedtime for 6 weeks. Combined supplementation with glycine and tryptophan significantly decreased serum uric acid levels (from 7.1 mg/dL to 6.7 mg/dL, p = 0.004) before and after the trial. Serum uric acid concentrations significantly decreased in the subjects supplemented with the amino acid mixture compared with those in placebo-treated subjects (p = 0.028). In addition, the combination treatment with glycine and tryptophan decreased serum triglyceride levels (from 119 mg/dL to 86 mg/dL, p = 0.002). Increased solubility of uric acid caused by urinary pH were likely contributors to the serum uric acid-lowering effects of the amino acid mixture.

Keywords: glycine; triglyceride; tryptophan; uric acid; urinary pH.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Cross-Over Studies
  • Dietary Supplements*
  • Double-Blind Method
  • Female
  • Glycine / administration & dosage*
  • Humans
  • Hyperuricemia / blood*
  • Hyperuricemia / therapy
  • Male
  • Middle Aged
  • Powders / administration & dosage
  • Treatment Outcome
  • Triglycerides / blood
  • Tryptophan / administration & dosage*
  • Uric Acid / blood*

Substances

  • Powders
  • Triglycerides
  • Uric Acid
  • Tryptophan
  • Glycine